ImageneBio, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
ImageneBio, Inc. (IMA) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price of $10.15 per share as of 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice · last filed 2026-03-10
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $10.15.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $10.41.
- 2025-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $4.44.
- 2025-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $4.49.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2025-12-31 | $10.15 10-K · filed 2026-03-10 |
| 2025-09-30 | $10.41 10-Q · filed 2025-11-12 |
| 2025-06-30 | $4.44 10-Q · filed 2025-07-24 |
| 2025-03-31 | $4.49 10-Q · filed 2025-05-08 |
| 2024-12-31 | $5.02 10-K · filed 2025-03-06 |
| 2024-09-30 | $5.01 10-Q · filed 2024-11-07 |
| 2024-06-30 | $5.20 10-Q · filed 2024-08-08 |
| 2023-12-31 | $6.35 10-K · filed 2024-03-12 |
| 2022-12-31 | $7.29 10-K · filed 2023-03-14 |
| 2022-09-30 | $7.32 10-Q · filed 2022-11-07 |
| 2022-06-30 | $7.54 10-Q · filed 2022-08-11 |
| 2022-03-31 | $7.71 10-Q · filed 2022-05-12 |
| 2021-12-31 | $7.17 10-K · filed 2022-03-17 |
| 2021-09-30 | $6.55 10-Q · filed 2021-11-10 |
| 2021-06-30 | $6.12 10-Q · filed 2021-08-12 |
| 2021-03-31 | $6.64 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |